Gliclazide 60mg + Pioglitazone 15mg + Metformin 500mg Tablets

Product Introduction

Gliclazide 60mg + Pioglitazone 15mg + Metformin 500mg is a three-medicine oral diabetes combination for selected adults with type 2 diabetes when gliclazide, pioglitazone, and metformin are all prescribed. Because it combines three medicine components, the benefit must be balanced against more safety checks. Gliclazide can cause hypoglycaemia, especially if meals are missed or other diabetes medicines are added. Pioglitazone can cause fluid retention, weight gain, edema, and may worsen or trigger heart failure in susceptible patients.

How to use

Take Gliclazide 60mg + Pioglitazone 15mg + Metformin 500mg with meals exactly as prescribed. Keep regular meals, glucose checks, kidney/liver monitoring, and follow-up for weight gain, swelling, or breathlessness.

How it works

Gliclazide increases insulin release, pioglitazone improves insulin sensitivity, and metformin reduces liver glucose production and improves insulin response.

Common side effects

Possible effects include hypoglycaemia, nausea, diarrhea, headache, dizziness, weight gain, edema, flatulence, and upper respiratory symptoms. Serious concerns include severe low sugar, lactic acidosis risk, liver problems, fluid retention, and heart-failure worsening.

Important information

Discuss heart failure, edema, kidney disease, liver disease, bladder cancer history, fractures, heavy alcohol use, dehydration, severe infection, contrast scans, pregnancy, breastfeeding, insulin, and other diabetes medicines.